Repeat and Consensus Proteins: Stability, Cooperativity, Function, & Design
重复蛋白和共有蛋白:稳定性、协同性、功能、
基本信息
- 批准号:10159263
- 负责人:
- 金额:$ 34.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-03-01 至 2022-09-19
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary
The broad objectives are 1) to determine the mechanisms by which protein stability is achieved,
and in particular, how stabilities of distant segments of proteins influence each other, giving rise
to cooperativity, using a combination of natural and designed repeat proteins, and 2) to
understand and leverage phylogenic-based consensus approaches to design proteins for high
stability and high levels of activity. These objectives will be achieved through three specific
aims. 1) Apply our nearest-neighbor 1D Ising formalism that we developed for natural repeat
proteins to quantify local folding and nearest neighbor coupling energies to a series of de novo
designed helical repeat proteins from the Baker lab. In parallel, we will measure folding kinetics,
using the energy landscape framework that results from the Ising analysis as a framework for
interpretation. Comparison to natural repeat proteins will reveal differences in folding between
designed and natural proteins. 2) Apply consensus design methods that we have used to
stabilize linear repeat proteins to globular proteins of different folds, sizes, and functions, and 3)
determine the extent to which biological activity is maintained. In Aim 2, we have identified
sixteen targets, and have strong preliminary results for six. We will determine structures by
NMR and x-ray crystallography, and stabilities using solution thermodynamics and kinetics. We
will dissect the basis of increased stability using sequence and structure metrics, and compare
with the "ancestral reconstruction" approach. In Aim 3, we will measure binding affinities,
specificities, and enzyme activities, and will focus on whether high stabilities decrease activity,
and whether dynamics changes is a general correlate.
All three of these aims will use large numbers of comparisons among different proteins
to build a statistically rigorous and general picture of design and consensus features, allowing
us to generalize, determining what works, what does not, and why. This is a significant
improvement over the one-off anecdotal studies that have been described to date.
Achieving these objectives will advance our understanding of the constraints on naturally
occurring protein sequences and evolution, and will address several paradigms including the "
principle of minimal frustration" and the "stability-activity tradeoff", and will identify key
differences between de novo-designed and natural protein sequences. These studies will
provide a deeper and more complete understanding of protein folding, and will also improve our
ability to design proteins for biotechnology and medicine.
项目摘要
广泛的目标是1)确定实现蛋白质稳定性的机制,
特别是,蛋白质遥远段的稳定性如何相互影响,产生
合作,使用天然和设计的重复蛋白的组合,以及2)
了解和利用基于系统的共识方法来设计高的蛋白质
稳定性和高水平的活动。这些目标将通过三个特定的
目标。 1)应用我们为自然重复开发的最近的邻居1D伊辛形式主义
蛋白质以量化局部折叠和最近的邻居耦合能与一系列从头开始
从贝克实验室设计了螺旋重复蛋白。同时,我们将测量折叠动力学,
使用由Ising分析导致的能源景观框架作为框架
解释。与自然重复蛋白的比较将揭示折叠的差异
设计和天然蛋白质。 2)应用我们过去的共识设计方法
将线性重复蛋白稳定到不同折叠,大小和功能的球状蛋白上,3)
确定维持生物学活性的程度。在AIM 2中,我们已经确定
16个目标,并具有六个目标的强烈初步结果。我们将通过
NMR和X射线晶体学,以及使用溶液热力学和动力学的稳定性。我们
将使用序列和结构指标来剖析稳定性提高的基础,并比较
采用“祖先重建”方法。在AIM 3中,我们将衡量具有约束力的亲和力,
特异性和酶活性,将集中于高稳定性是否会降低活动,
并且动态是否改变是一般相关性。
这三个目标将使用不同蛋白质之间的大量比较
构建设计和共识特征的统计严格和一般图片,允许
我们概括,确定什么有效,什么无效以及为什么。这是重要的
迄今为止已经描述的一次性轶事研究的改进。
实现这些目标将提高我们对自然限制的理解
发生蛋白质序列和进化,将解决包括“
最小的挫败感原则和“稳定性活动权衡”,将确定关键
从头设计和天然蛋白质序列之间的差异。这些研究会
提供对蛋白质折叠的更深入,更完整的了解,也将改善我们的
能够设计生物技术和医学的蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
DOUGLAS E. BARRICK的其他基金
Repeat Proteins; Stability, Folding Kinetics & Evolution
重复蛋白质;
- 批准号:89212088921208
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
Repeat-Proteins; Stability, Folding Kinetics & Evolution
重复蛋白质;
- 批准号:76544087654408
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
Consensus and Covariance Proteins: Stability, Cooperativity, Function, & Design
共识和协方差蛋白质:稳定性、协作性、功能、
- 批准号:1053497310534973
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
REPEAT-PROTEINS; STABILITY, FOLDING KINETICS & EVOLUTION
重复-蛋白质;
- 批准号:73709917370991
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
Consensus and Covariance Proteins: Stability, Cooperativity, Function, & Design
共识和协方差蛋白质:稳定性、协作性、功能、
- 批准号:1079838610798386
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
REPEAT-PROTEINS; STABILITY, FOLDING KINETICS & EVOLUTION
重复-蛋白质;
- 批准号:69300996930099
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
REPEAT-PROTEINS; STABILITY, FOLDING KINETICS & EVOLUTION
重复-蛋白质;
- 批准号:71933807193380
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
Repeat Proteins; Stability, Folding Kinetics & Evolution
重复蛋白质;
- 批准号:90630679063067
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
Consensus and Covariance Proteins: Stability, Cooperativity, Function, & Design
共识和协方差蛋白质:稳定性、协作性、功能、
- 批准号:1070733010707330
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
REPEAT-PROTEINS; STABILITY, FOLDING KINETICS & EVOLUTION
重复-蛋白质;
- 批准号:70258217025821
- 财政年份:2005
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:1075148010751480
- 财政年份:2024
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:1067834110678341
- 财政年份:2023
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
High-throughput thermodynamic and kinetic measurements for variant effects prediction in a major protein superfamily
用于预测主要蛋白质超家族变异效应的高通量热力学和动力学测量
- 批准号:1075237010752370
- 财政年份:2023
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:1072488210724882
- 财政年份:2023
- 资助金额:$ 34.82万$ 34.82万
- 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:1075730910757309
- 财政年份:2023
- 资助金额:$ 34.82万$ 34.82万
- 项目类别: